Evolution of patients with Sézary syndrome after mogamulizumab discontinuation for any cause except progression: a multicenter retrospective study (Moga-stop study)
Langue
EN
Article de revue
Ce document a été publié dans
British Journal of Dermatology. 2024-04-25p. ljae153
Résumé en anglais
The results of this study suggest that a progressive discontinuation of mogamulizumab should be considered once response is obtained in Sezary syndrome patients, even after a treatment of short-duration. This may possibly ...Lire la suite >